197 related articles for article (PubMed ID: 34590470)
1. Methylation alterations and advance of treatment in lymphoma.
Liu MK; Sun XJ; Gao XD; Qian Y; Wang L; Zhao WL
Front Biosci (Landmark Ed); 2021 Sep; 26(9):602-613. PubMed ID: 34590470
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma.
Zhang P; Zhang M
Clin Epigenetics; 2020 Nov; 12(1):169. PubMed ID: 33160401
[TBL] [Abstract][Full Text] [Related]
3. The many layers of epigenetic dysfunction in B-cell lymphomas.
Jiang Y; Dominguez PM; Melnick AM
Curr Opin Hematol; 2016 Jul; 23(4):377-84. PubMed ID: 27055146
[TBL] [Abstract][Full Text] [Related]
4. Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified.
Ji MM; Huang YH; Huang JY; Wang ZF; Fu D; Liu H; Liu F; Leboeuf C; Wang L; Ye J; Lu YM; Janin A; Cheng S; Zhao WL
Haematologica; 2018 Apr; 103(4):679-687. PubMed ID: 29305415
[TBL] [Abstract][Full Text] [Related]
5. Targeting DNA Methylation in Leukemia, Myelodysplastic Syndrome, and Lymphoma: A Potential Diagnostic, Prognostic, and Therapeutic Tool.
Kalinkova L; Sevcikova A; Stevurkova V; Fridrichova I; Ciernikova S
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614080
[TBL] [Abstract][Full Text] [Related]
6. The role of epigenetics in T-cell lymphoma.
Yamagishi M
Int J Hematol; 2022 Dec; 116(6):828-836. PubMed ID: 36239901
[TBL] [Abstract][Full Text] [Related]
7. Hypomethylating Agents in Lymphoma.
Cogan JC; Liu Y; Amengual JE
Curr Treat Options Oncol; 2020 Jun; 21(8):61. PubMed ID: 32601883
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic alterations and advancement of lymphoma treatment.
Zhuang S; Yang Z; Cui Z; Zhang Y; Che F
Ann Hematol; 2024 May; 103(5):1435-1454. PubMed ID: 37581713
[TBL] [Abstract][Full Text] [Related]
9. Clinical advances in epigenetic therapies for lymphoma.
Rosenthal AC; Munoz JL; Villasboas JC
Clin Epigenetics; 2023 Mar; 15(1):39. PubMed ID: 36871057
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic dysregulation in follicular lymphoma.
Araf S; Okosun J; Koniali L; Fitzgibbon J; Heward J
Epigenomics; 2016 Jan; 8(1):77-84. PubMed ID: 26698557
[TBL] [Abstract][Full Text] [Related]
11. Methylation changes of SIRT1, KLF4, DAPK1 and SPG20 in B-lymphocytes derived from follicular and diffuse large B-cell lymphoma.
Frazzi R; Zanetti E; Pistoni M; Tamagnini I; Valli R; Braglia L; Merli F
Leuk Res; 2017 Jun; 57():89-96. PubMed ID: 28324774
[TBL] [Abstract][Full Text] [Related]
12. Combinatorial epigenetic therapy in diffuse large B cell lymphoma pre-clinical models and patients.
Pera B; Tang T; Marullo R; Yang SN; Ahn H; Patel J; Elstrom R; Ruan J; Furman R; Leonard J; Cerchietti L; Martin P
Clin Epigenetics; 2016; 8():79. PubMed ID: 27453763
[TBL] [Abstract][Full Text] [Related]
13. Aberrant DNA methylation of key genes and Acute Lymphoblastic Leukemia.
Rahmani M; Talebi M; Hagh MF; Feizi AAH; Solali S
Biomed Pharmacother; 2018 Jan; 97():1493-1500. PubMed ID: 29793312
[TBL] [Abstract][Full Text] [Related]
14. Compendium of aberrant DNA methylation and histone modifications in cancer.
Hattori N; Ushijima T
Biochem Biophys Res Commun; 2014 Dec; 455(1-2):3-9. PubMed ID: 25194808
[TBL] [Abstract][Full Text] [Related]
15. Epigenetics and Lymphoma: Can We Use Epigenetics to Prime or Reset Chemoresistant Lymphoma Programs?
Lue JK; Amengual JE; O'Connor OA
Curr Oncol Rep; 2015 Sep; 17(9):40. PubMed ID: 26141799
[TBL] [Abstract][Full Text] [Related]
16. Aberrant epigenetic gene regulation in lymphoid malignancies.
Taylor KH; Briley A; Wang Z; Cheng J; Shi H; Caldwell CW
Semin Hematol; 2013 Jan; 50(1):38-47. PubMed ID: 23507482
[TBL] [Abstract][Full Text] [Related]
17. Methylation contributes to imbalance of PRDM1α/PRDM1bβ expression in diffuse large B-cell lymphoma.
Zhang YW; Zhang J; Li J; Zhu JF; Yang YL; Zhou LL; Hu ZL; Zhang F
Leuk Lymphoma; 2015; 56(8):2429-38. PubMed ID: 25487076
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and treatment of lymphomas in the era of epigenetics.
Chebly A; Chouery E; Ropio J; Kourie HR; Beylot-Barry M; Merlio JP; Tomb R; Chevret E
Blood Rev; 2021 Jul; 48():100782. PubMed ID: 33229141
[TBL] [Abstract][Full Text] [Related]
19. Current clinical trials for epigenetic targets and therapeutic inhibitors for pancreatic cancer therapy.
Ganji C; Farran B
Drug Discov Today; 2022 May; 27(5):1404-1410. PubMed ID: 34952224
[TBL] [Abstract][Full Text] [Related]
20. The epigenetic basis of diffuse large B-cell lymphoma.
Jiang Y; Melnick A
Semin Hematol; 2015 Apr; 52(2):86-96. PubMed ID: 25805588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
